Prevalence and predictors of complementary therapy use in advanced-stage breast cancer patients

Journal of Oncology Practice

Volumn 3, Issue 6, 2007, Pages 292-295

  Gross, Abigail M ^a   Liu, Qin ^b   Bauer Wu, Susan ^c  

^a Columbia University ^*  (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; HERBACEOUS AGENT; HORMONE; VITAMIN;

ADULT; ADVANCED CANCER; ALTERNATIVE MEDICINE; ARTICLE; BREAST CANCER; CANCER HORMONE THERAPY; CANCER PATIENT; CANCER STAGING; CONTROLLED STUDY; DEMOGRAPHY; EDUCATION; EXERCISE; FEMALE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MEDICAL RECORD; METASTASIS POTENTIAL; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PREDICTION; PREVALENCE; RELIGION; STATISTICAL SIGNIFICANCE; UNITED STATES;

EID: 42649085407     PISSN: 15547477     EISSN: None     Source Type: Journal    
DOI: 10.1200/JOP.0762001     Document Type: Article

References (23)

1. Yates J, Mustian K, Morrow G, et al: Prevalence of complementary and alternative medicine use in cancer patients during treatment. Support Care Cancer 13:806-811, 2005
2. Richardson M, Sanders T, Palmer J, et al: Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. J Clin Oncol 18:2505-2514, 2000
3. Kelly K, Jacobsen J, Kennedy D, et al. Use of unconventional therapies by children with cancer at an urban medical center. J Ped Hematol Oncol 22:412-416, 2000
4. Patterson R, Neuhouser M, Hedderson M, et al: Types of alternative medicine used by patients with breast, colon, or prostate cancer: Predictors, motives, and costs. J Alt Comp Med 8:477-485, 2002
5. National Center for Complementary and Alternative Medicine: Definition and categories of CAM. http://nccam.nih.gov/health/whatiscam/
6. Molassiotis A, Scott J, Kearney N, et al: Complementary and alternative medicine use in breast cancer patients in Europe. Supportive Care in Cancer 14:260-267, 2006
7. Dy G, Bekele L, Hanson L, et al: Complementary and alternative medicine use by patients enrolled onto phase I clinical trials. J Clin Oncol 22:4810-4815, 2004
8. Morris, K, Johnson N, Homer L, et al: A comparison of complementary therapy use between breast cancer patients and patients with other primary tumor sites. Am J Surg 179:407-411, 2000
9. Boon H, Brown J, Gavin A, et al: Breast cancer survivors' perceptions of complementary/alternative medicine(CAM): Making the decision to use or not to use. Qualitative Health Research 9:639-653, 1999
10. Sparber A, Bauer L, Curt G, et al: Use of complementary medicine by adult patients participating in cancer clinical trials. Oncol Nurs Forum 27:623-630, 2000
11. Taglieferri M, Cohen I, Tripathy D: Complementary and alternative medicine in early-stage breast cancer. Semin Oncol 28:121-134, 2001
12. Boon H, Stewart M, Kennard M, et al: Use of complementary/alternative medicine by breast cancer survivors in Ontario: Prevalence and perceptions. J Clin Oncol 18:2515-2521, 2000
13. Hann D, Baker F, Robert C, et al: Use of complementary therapies among breast and prostate cancer patients during treatment: A multisite study. Integrative Cancer Therapies 4:294-300, 2005
14. Henderson K, Daonatelle R: Complementary and alternative medicine use by women after completion of allopathic treatment for breast cancer. Alternative Therapies in Health and Medicine 10:52-57, 2004
15. Lengacher C, Bennett M, Kip K. et al: Frequency of use of complementary and alternative medicine in women with breast cancer. Oncol Nurs Forum 29: 1445-1452, 2002
16. Shen J, Andersen R, Albert P, et al: Use of complementary/alternative therapies by women with advanced-stage breast cancer. BMC Complementary and Alternative Medicine 2:8, 2002 http://www.biomedcentral.com/content/ pdf/1472-6882-2-8.pdf
17. Burstein H, Gelber S, Guadagnoli E, et al: Use of alternative medicine by women with early-stage breast cancer. N Engl J Med 340:1733-1739, 1999
18. DiGianni L, Garber J, Winer E: Complementary and alternative medicine use among women with breast cancer. J Clin Oncol 20:34s-38s, 2002
19. Bauer-Wu S, Liu O, Hsieh C-G, et al: Expressive writing for metastatic breast cancer patients: Effects on symptoms, adjustment, and quality of life three months later. 8th National Conference on Cancer Nursing Research, Ft Lauderdale, FL, February 3-5, 2005
20. Navo M, Phan J, Vaughan C, et al: An assessment of the utilization of complementary and alternative medication in women with gynecologist or breast malignancies. J Clin Oncol 22:671-677, 2004
21. Fugh-Berman A: Herb-drug interactions. Lancet 355:134-138, 2000
22. Izzo AA: Herb-drug interactions: An overview of the clinical evidence. Fundamental Clin Pharma 19:1-16, 2005
23. Rosenthal D, Dean-Clower E: Integrative medicine in hematology/oncology: Benefits, ethical considerations, and controversies. Hematol 491-497, 2005